Pallas Capital Advisors LLC Grows Stake in DENTSPLY SIRONA Inc. $XRAY

Pallas Capital Advisors LLC raised its position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 83.2% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 82,171 shares of the medical instruments supplier’s stock after buying an additional 37,306 shares during the quarter. Pallas Capital Advisors LLC’s holdings in DENTSPLY SIRONA were worth $1,305,000 as of its most recent SEC filing.

Several other institutional investors have also added to or reduced their stakes in the company. Gabelli Funds LLC grew its holdings in DENTSPLY SIRONA by 1.0% during the 1st quarter. Gabelli Funds LLC now owns 98,000 shares of the medical instruments supplier’s stock valued at $1,464,000 after buying an additional 1,000 shares in the last quarter. Empowered Funds LLC grew its holdings in DENTSPLY SIRONA by 8.8% during the 1st quarter. Empowered Funds LLC now owns 16,324 shares of the medical instruments supplier’s stock valued at $244,000 after buying an additional 1,320 shares in the last quarter. Covestor Ltd grew its holdings in DENTSPLY SIRONA by 17.5% during the 1st quarter. Covestor Ltd now owns 9,778 shares of the medical instruments supplier’s stock valued at $146,000 after buying an additional 1,456 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. purchased a new position in DENTSPLY SIRONA during the 1st quarter valued at approximately $25,000. Finally, Principal Financial Group Inc. grew its holdings in DENTSPLY SIRONA by 0.4% during the 1st quarter. Principal Financial Group Inc. now owns 457,397 shares of the medical instruments supplier’s stock valued at $6,834,000 after buying an additional 1,708 shares in the last quarter. Hedge funds and other institutional investors own 95.70% of the company’s stock.

DENTSPLY SIRONA Trading Down 0.1%

Shares of NASDAQ XRAY opened at $13.42 on Friday. The company has a quick ratio of 1.11, a current ratio of 1.69 and a debt-to-equity ratio of 1.13. The business has a fifty day simple moving average of $14.50 and a two-hundred day simple moving average of $14.94. The firm has a market cap of $2.68 billion, a PE ratio of -2.83, a price-to-earnings-growth ratio of 0.84 and a beta of 0.96. DENTSPLY SIRONA Inc. has a twelve month low of $12.16 and a twelve month high of $27.44.

DENTSPLY SIRONA (NASDAQ:XRAY) last issued its earnings results on Thursday, August 7th. The medical instruments supplier reported $0.52 earnings per share for the quarter, beating analysts’ consensus estimates of $0.50 by $0.02. The business had revenue of $936.00 million during the quarter, compared to analyst estimates of $929.67 million. DENTSPLY SIRONA had a positive return on equity of 16.33% and a negative net margin of 25.85%.DENTSPLY SIRONA’s revenue was down 4.9% on a year-over-year basis. During the same period in the previous year, the company posted $0.49 EPS. DENTSPLY SIRONA has set its FY 2025 guidance at 1.800-2.000 EPS. Analysts expect that DENTSPLY SIRONA Inc. will post 1.84 earnings per share for the current fiscal year.

DENTSPLY SIRONA Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, October 10th. Shareholders of record on Friday, September 26th will be given a dividend of $0.16 per share. The ex-dividend date of this dividend is Friday, September 26th. This represents a $0.64 dividend on an annualized basis and a yield of 4.8%. DENTSPLY SIRONA’s payout ratio is -13.50%.

Analyst Ratings Changes

Several equities analysts have weighed in on XRAY shares. Stifel Nicolaus cut their price target on DENTSPLY SIRONA from $19.00 to $17.00 and set a “hold” rating for the company in a report on Friday, August 8th. Needham & Company LLC restated a “hold” rating on shares of DENTSPLY SIRONA in a report on Monday, July 21st. Wall Street Zen cut DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a report on Saturday, August 9th. Barrington Research dropped their target price on DENTSPLY SIRONA from $21.00 to $18.00 and set an “outperform” rating for the company in a report on Friday, August 8th. Finally, UBS Group dropped their target price on DENTSPLY SIRONA from $25.00 to $24.00 and set a “buy” rating for the company in a report on Friday, August 8th. Two research analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Hold” and a consensus price target of $18.64.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.